Literature DB >> 15630907

Hyperkalemia-induced ECG abnormalities in patients with reduced renal function.

C Esposito1, N Bellotti, G Fasoli, A Foschi, A R Plati, A Dal Canton.   

Abstract

Hyperkalemia is a potentially lethal condition to be aware of in the presence of ECG abnormalities especially in patients with reduced renal function. However, ECG abnormalities are not always dependent on the degree ofhyperkalemia but may be aggravated by the rapidity of the development of hyperkalemia and by associated electrolyte disorders. We describe 3 patients with renal failure and different ECG changes induced by hyperkalemia. More severe changes were observed when hyperkalemia developed rapidly, but not in presence of electrolyte disorders. Even minor ECG abnormalities must alarm physicians in patients with renal failure since severe hyperkalemia is not always associated with critical ECG changes.

Entities:  

Mesh:

Year:  2004        PMID: 15630907     DOI: 10.5414/cnp62465

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  8 in total

Review 1.  ECG frequency changes in potassium disorders: a narrative review.

Authors:  Navid Teymouri; Sahar Mesbah; Seyed Mohammad Hossein Navabian; Dorsa Shekouh; Mahsa Mohammadi Najafabadi; Narges Norouzkhani; Mohadeseh Poudineh; Mohammad Sadegh Qadirifard; Saba Mehrtabar; Niloofar Deravi
Journal:  Am J Cardiovasc Dis       Date:  2022-06-15

2.  The frequency of hyperkalemia and its significance in chronic kidney disease.

Authors:  Lisa M Einhorn; Min Zhan; Van Doren Hsu; Lori D Walker; Maureen F Moen; Stephen L Seliger; Matthew R Weir; Jeffrey C Fink
Journal:  Arch Intern Med       Date:  2009-06-22

3.  Anaesthesia for renal transplantation: an update.

Authors:  Vaibhavi Baxi; Anand Jain; D Dasgupta
Journal:  Indian J Anaesth       Date:  2009-04

4.  Hyperkalemic recurrent bilateral lower extremity weakness in a patient on hemodialysis.

Authors:  Getaw Worku Hassen; Suzanne Newstead; Lorraine Maria Giordano
Journal:  Case Rep Emerg Med       Date:  2012-05-13

5.  Acute Ascending Flaccid Paralysis Secondary to Multiple Trigger Factor Induced Hyperkalemia.

Authors:  K H D Thilini Hemachandra; M B Kavinda Chandimal Dayasiri; Thamara Kannangara
Journal:  Case Rep Neurol Med       Date:  2018-05-29

6.  The value of maintaining normokalaemia and enabling RAASi therapy in chronic kidney disease.

Authors:  Marc Evans; Eirini Palaka; Hans Furuland; Hayley Bennett; Cecilia Linde; Lei Qin; Phil McEwan; Ameet Bakhai
Journal:  BMC Nephrol       Date:  2019-01-31       Impact factor: 2.388

7.  Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom.

Authors:  Cecilia Linde; Ameet Bakhai; Hans Furuland; Marc Evans; Phil McEwan; Daniel Ayoubkhani; Lei Qin
Journal:  J Am Heart Assoc       Date:  2019-11-12       Impact factor: 5.501

8.  Serum potassium as a predictor of adverse clinical outcomes in patients with increasing comorbidity burden.

Authors:  Eskinder Tafesse; Michael Hurst; Daniel Sugrue; Louise Hoskin; Karolina Badora; Lei Qin; Glen James; Phil McEwan
Journal:  Eur Heart J Qual Care Clin Outcomes       Date:  2022-01-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.